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Embryonic stem (ES) cells rely on growth factors provided by feeder cells or exogenously to maintain their pluripotency. In order to identify
such factors, we have established sub-lines of STO feeder cells which exhibit variable ability in supporting ES cell self-renewal. Functional
screening identifies WNT5A and WNT6 as STO cell-produced factors that potently inhibit ES cell differentiation in a serum-dependent manner.
Furthermore, direct activation of h-catenin without disturbing the upstream components of the WNT/h-catenin pathway fully recapitulates the
effect of WNTs on ES cells. Importantly, the WNT/h-catenin pathway up-regulates the mRNA for Stat3, a known regulator of ES cell self-renewal
in the mouse. Finally, LIF is able to mimic the serum effect to act synergistically with WNT proteins to inhibit ES cell differentiation. Therefore,
our study reveals part of the molecular mechanisms by which the WNT/h-catenin pathway acts to prevent ES cell differentiation through
convergence on the LIF/JAK-STAT pathway at the level of STAT3.
D 2005 Elsevier Inc. All rights reserved.Keywords: Embryonic stem cells; Growth factors; Pluripotency; Mouse; WNT/h-catenin; STAT3Introduction
Embryonic stem (ES) cells are pluripotent stem cells that
are able to form all cell types of the body by following
normal embryogenesis or through forced differentiation with
proper instructional cues (Evans and Kaufman, 1981;
Martin, 1981). It is generally accepted that the pluripotency
of ES cells holds great promise for these cells to be used in
tissue and cell therapy. However, the molecular and
developmental mechanisms regulating pluripotency are just
beginning to be elucidated. Through genetic studies, a
number of genes encoding intracellular regulatory proteins
have been shown to affect the fate decisions of the
pluripotent inner cell mass (ICM) or the epiblast. Among
these genes are Oct4, H2az, Foxd3, Nanog, and Sox2
(Chambers et al., 2003; Faast et al., 2001; Hanna et al.,
2002; Mitsui et al., 2003; Nichols et al., 1998; Niwa et al.,0012-1606/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
doi:10.1016/j.ydbio.2005.11.011
* Corresponding author. Fax: +1 214 645 6276.
E-mail address: guang.zhao@utsouthwestern.edu (G.-Q. Zhao).2000). Nevertheless, little is known about how these genes
coordinate with each other or with extracellular cues to
control pluripotency.
Growth factors required for ES cell self-renewal are
usually provided by feeder cells or exogenously (Smith,
2001). Leukemia inhibiting factor (LIF) and its close
relatives (IL6 family) were the only known pro-pluripotency
factors for mouse ES cells for many years. However, IL6
family has little effect on primate ES cells. By contrast,
FGF2 appears to prevent primate ES cell differentiation
(Thomson and Odorico, 2000). Our previous study reported
the establishment of different sub-lines of STO cells (a
mouse embryonic fibroblast cell line) with different ability
to support the self-renewal of mouse ES cells (Qi et al.,
2004). A-STO is more potent than R-STO in preventing ES
cell differentiation. Gene expression profiling, RT-PCR, and
Western blots revealed that BMP4 was expressed at higher
levels in A-STO than in R-STO and was at least partially
responsible for the pro-pluripotency effect (Qi et al., 2004).
Here, we report the extension of our previous studies with
the identification and analysis of additional pro-pluripotency
factors.290 (2006) 81 – 91
www.e
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Cell cultures
The establishment and culture of Oct4-GFP ES cells were described (Qi et
al., 2004). Complete ES cell medium is composed of DMEM (InVitrogen
#12800-017) with 4 mM l-glutamine, 4.5 g glucose/l, 1.5 g sodium
bicarbonate/l, 100 U penicillin/ml, 100 Ag streptomycin/ml, 55 AM 2-
mercaptoethanol, 100 AM non-essential amino acid, 20% fetal bovine serum
(FBS) (Hyclone ES cell qualified), and LIF at 1000 U/ml. For serum-free ES
medium, 10% knockout serum replacement (KSR) (InVitrogen) replaces FBS.
STO cells were routinely cultured in DMEM, 4 mM l-glutamine, 4.5 g
glucose/l, 1.5 g sodium bicarbonate/l, 100 U penicillin/ml, 100 Ag streptomy-
cin/ml, and 10% FBS. The establishment of STO sub-lines from parental STO
(purchased from ATCC) was as described (Qi et al., 2004). One of the sub-lines
that shows the least effectiveness in supporting ES cells, named C-STO, was
used to express WNT5A, WNT6, and WNT3. Treatment of feeder cells with
mitomycin C (10 Ag/ml) and further handling were as described (Hogan et al.,
1994). To prepare conditioned medium, 4  106 control L cells, L cells
expressing WNT3A, or STO cells were plated in 100-mm dishes, cultured with
10 ml STO cell medium for 12–16 h, and then cultured in serum-free ES cell
media without LIF. After for 48 h, the serum-free conditioned medium was
collected, filtered to remove cell debris, and used to culture ES cells
immediately or were stored at 4-C for no more than 1 week before use.
DNA constructs and transfection
The CAG-puro construct was generated as described previously (Qi et al.,
2004). The coding regions of mouse Wnt5a, Wnt6, Wnt3, and h-catenin-ER
were inserted between the CAG promoter and the IRES to generate CAG-
Wnt5a, CAG-Wnt6, CAG-Wnt3, and CAG-h-catenin-ER, respectively. Plas-
mid transfection into STO and ES cells was carried out by electroporation
essentially as reported (Qi et al., 2004). After transfection, STO cells were
selected with 1.5 Ag/ml puromycin for 7 days, and the mixture of resistant cells
(not single clones) were used as feeder cells, while ES cells were selected in the
presence of 1.5 Ag/ml puromycin for 7–10 days to obtain positive clones.
RNA purification and RT-PCR
To examine whether and which frizzled receptors were expressed in ES
cells, it was important to eliminate STO cell contamination. To accomplish this,
three ES cell lines were cultured continuously on COS-Bmp4 feeder cells for 5
passages in complete ES cell medium before RNA extraction (Qi et al., 2004).
Unlike STO cells, which are of mouse origin, COS cells are a monkey cell line.
RNA extraction, 1st strand cDNA synthesis, and RT-PCR procedures were
essentially as described (Qi et al., 2004). For primer sequences, please refer to
Table 1.
For differential gene expression study, ES cells were harvested from
cultures on STO-NL cells which contained Neor and human LIF expression
cassettes, the most commonly used STO sub-line for mouse ES cell culture, in
complete ES cell medium. Cells were attached twice on gelatinized plates to
remove feeder cells, washed with PBS to remove serum, and re-suspended in
serum-free medium containing 10% KSR without LIF. These cells were
maintained in this medium for 2 h in the incubator, then aliquots of 2  107
cells were pelleted, re-suspended in WNT3A or control conditioned medium,
and cultured for 6 h in the incubator before RNA purification. ES cells
expressing h-catenin-ER fusion proteins were similarly handled but cultured in
serum-free medium with or without 100 nM 4-hydroxytamoxifen (4-OHT) for
a given period before RNA purification. For protein synthesis inhibition,
cyclohexamide at 10 Ag/ml was added to h-catenin-ER ES cells in serum-free
medium and incubated at 37-C for 1 h before adding 4-OHT and continued
culture at 37-C for additional 4 h before RNA purification.
Western blots
For Western blots to detect h-catenin, wild-type ES cells were harvested
from cultures on STO-NL cells. Cells in complete ES cell medium wereattached twice on gelatinized plates to remove feeders, washed with PBS, and
re-suspended in serum-free medium without LIF. ES cells were maintained in
this medium for 2 h to recover in the incubator, then aliquots of 2  107 cells
were pelleted, re-suspended in respective conditioned media, and culture
continued for 2 or 5 h for whole cell extracts. For STAT3 Western blots, ES
cells expressing h-catenin-ER were handled as described for RNA purification
and cultured in serum-free medium with or without 4-OHT for 4 or 8 h before
harvest for whole cell extracts. The extracts were first normalized with a-
tubulin and then subjected to Western blots for h-catenin or STAT3. Anti-h-
catenin and anti-STAT3 antibodies were purchased from Cell Signaling (#9561,
9562, 9131, and 9132) and anti-Tubulin antibody was purchased from
BioGenex (#MU121-UC).
Chimeric mice generation
ES cells were continuously cultured on C-STO, C-STO-Wnt3, C-STO-
Wnt5a, and C-STO-Wnt6 feeder cells in complete ES cell medium without LIF
and were passed every 5 days. ES cells on C-STO cells differentiated and lost
their ability to form colonies after 2 passages. Thus, no effort was made to
generate chimeric mice with these cells. ES cells cultured on the three WNT
producing feeders were passed 6 times before being sent to UT Southwestern
Transgenic Center for microinjection to generate chimeric mice. Contribution
of ES cells to chimeras was based on their coat color scored by the personnel of
UT Southwestern Transgenic Center.
Results
Three STO sub-lines with different potency in supporting ES
cell self-renewal
We previously reported that the mouse embryonic fibroblast
STO cell line from ATCC was heterogeneous. This allowed us
to establish sub-lines with variable ability to support ES cell
self-renewal (Qi et al., 2004). Two sub-lines, A-STO (an ES
cell-supporting STO) and R-STO (an ES cell non-supporting
STO) (Figs. 1A–D), were characterized. Gene expression
profiling revealed that BMP4 was expressed at higher levels in
A-STO than in R-STO and was partially responsible for the
pro-pluripotency effect of A-STO. Here, we report another sub-
line of STO cells, C-STO, which exhibits the least ability to
support the self-renewal of ES cells among 120 sub-lines
screened. As shown in Figs. 1E and F, in low-density culture,
individual ES cells formed spread colonies on C-STO in
complete ES cell medium for 7 days. Most of the colonies lost
Oct4-GFP expression. Interestingly, addition of BMP4 at 50
ng/ml did not correct the deficiency of C-STO (data not
shown), suggesting that factors other than BMPs were
responsible for the difference between A-STO and C-STO.
To identify the factors that were present in A-STO, but not
in C-STO (or at low levels in C-STO), we compared gene
expression profiles of A-STO and C-STO using Affymetrix
murine A chips. Among the many genes differentially
expressed, 27 genes encoding growth factors or extracellular
proteins were expressed at higher levels in A-STO than in C-
STO (1.5- to 188-fold) and were selected for further analysis.
These include Igfbp4, Igfbp10, Igf1, Igf2, Wnt5a, Wnt6, Gas6,
Wisp1, Wisp2, Follistatin, Follistatin-like, Dan, Hgf, Tnf
member9, Hbegf-like, CC chemokine, Tgfb3, Ngf-b, sFrp1,
Gdnf, Mg-csf, Vegf, Ctgf, Proliferin, Bdnf, E-selectin ligand1,
and Mgf (Table 2). Also shown in Table 2, Bmp4 appears to be
expressed at similar levels in A-STO and C-STO, further
Table 1
RT-PCR primer sequences
Hprt F TGGTTAAGGTTGCAAGCTTGCTGGTGA
R GGGTAGGCTGGCCTATAGGCTCATAGT
Frizzled1 F TACAGTCTTCATGATCAAGTATCTC
R ACTGCGTGTTCGATAGTCTTTAA
Frizzled2 F GCTTCGTGTCACTCTTCCGCATC
R TGAGTGAAGGAGGGGACGGTGCA
Frizzled3 F AGTGTCCACAGCAAAGTGAGCAG
R TGTGATGACATGATCCTTAGGTT
Frizzled4 F AGATGACTCAAACATGGCAGTTGAA
R TCCCACCCAGTAGGAGCAAACACTAT
Frizzled5 F GAAGCAGGCCTGGAGGTGCACCAA
R AGATGAAGCACAGCACAGACCACA
Frizzled6 F ACCGGAATGGCAGGGAAAGCCGAG
R AAGCTGGTTTAAGTGCAAGGAAGAC
Frizzled7 F GCATCCGCACCATCATGAAGCACGA
R CAGGTAGCTTACGGAAACAAGCC
Frizzled8 F GGTACCTGTTGGAAGTGACCTCGCT
R CGTTCGCTGGACACGCTCACCAT
Frizzled9 F TGCTGCTGTGGCAGCTGCTGGCGAC
R AGCGTTCTCGGGTGCCTCCATACA
Stat3 F CCATGCTGAGCATCGAGCAGCTGACA
R TCACACAGATGAACTTGGTCTTCAGG
Nanog F GCGCATCGATCTATGATCTTTCCTTCTAGACACTGAG
R CGACGCTAGCGACAATTAGAGCTATGCAGAGAAACC
Oct4 F ACTAATACGACTCACTATAGGATGGCATACTGTGGACCTCA
R ACTAATACGACTCACTATAGGTTCTCAATGCTAGTTCGCTTTC
Id1 F CAGGATCATGAAGGTCGCCAGTGG
R AGTGCGCCGCCTCAGCGACACAAGA
Id2 F ACGAGCAGCATGAAAGCCTTCAGT
R TTAGCCACAGAGTACTTTGCTATC
Id3 F TCTCCAACATGAAGGCGCTGAGCCC
R GTCAGTGGCAAAAGCTCCTCTTGTCC
Brachyury F GAGCCTGCAGTACCGAGTGGAC
R TGTAATCTCCTCATTCTGGTAG
Axin2 F TCACCATGAGTAGCGCCGTGTTAGTG
R TGGATCTCGGTCTGTGCCTGGTCAA
Pitx2 F ATGCAATCGATGGAGACCAATTGTCGCAAACTAG
R ATATAGCTAGCTTCACACCGGCCGGTCGACTGCATACT
Wnt5a F ATGTCTTCCAAGTTCTTCCTAATGGC
R GCTCAGCCACAGGTAGACAGCTCG
Wnt6 F CTTGGTCATGGATCCTACCAGCATCT
R TCGTTGTTGTGCAGTTGCACCAATGC
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between A-STO and C-STO.
WNT5A and WNT6 are potent inhibitors of mouse ES cell
differentiation
To identify the candidates among the twenty-seven secreted
proteins, the full coding cDNAs for these sequences were sub-
cloned into CAG-puro vector and transfected into C-STO cells
to obtain a mixture of puromycin-resistant cells. Each of the
cell mixtures, in turn, was used as feeder cells to test for their
ability to support the self-renewal of Oct4-GFP ES cells.
Expression for most of these cDNA, except for Wnt5a and
Wnt6, in C-STO failed to correct the deficiency of C-STO in
supporting ES cell propagation. The differential expression of
Wnt5a and Wnt6 among the three STO sub-lines was further
confirmed by semi-quantitative RT-PCR, showing that they
were essentially absent in C-STO and much reduced in R-STO(Fig. 1G). As shown in Figs. 2A–D, C-STO cells transfected
with CAG-Wnt5a maintained ES cells in the undifferentiated
state with robust Oct4-GFP expression, while ES cells cultured
on C-STO transfected with control vector CAG-puro in
medium containing 10% FBS without LIF spread and
completely lost Oct4-GFP expression. C-STO transfected with
CAG-Wnt6 had an effect similar to that of C-STO-Wnt5a (data
not shown). Although Wnt3 was not expressed at appreciable
level in A-STO or C-STO, it also prevented ES cell
differentiation when expressed in C-STO (Figs. 2E and F).
The same was true for L cells expressing WNT3A (Shibamoto
et al., 1998), while control L cells did not prevent ES cell
differentiation (data not shown). Thus, all four WNT proteins
(WNT3, WNT3A, WNT5A, and WNT6) similarly prevented
ES cell differentiation under these conditions. Moreover,
soluble frizzled receptor protein 1 (sFrp1), a negative regulator
of WNTs, was able to neutralize the effect of WNT3 and
WNT5A on ES cell colony formation by more than 30% (P <
Fig. 1. ES cell colonies grown on representative STO sub-lines. About 500 Oct4-GFP ES cells were plated on top of each feeder cell line in a 35-mm dish and were
cultured in complete ES cell medium for 7 days. Under these low-density conditions, most ES cell colonies originated from single cells. The left panels are
fluorescent photomicrographs showing Oct4-GFP and the right panels are dark-field to show the morphology of ES cell colonies. (A and B) ES cell colonies on A-
STO sub-line showing uniform Oct4-GFP expression. (C and D) ES cell colonies on R-STO with patchy GFP expression. (E and F) ES cell colonies on C-STO with
significant spreading and a complete (arrowheads) and partial loss (arrows) of GFP expression. (G) RT-PCR confirming the levels of Wnt5a and Wnt6 expression in
A-STO than in R-STO and C-STO. Hprt PCR was used for normalization. Scale bar = 700 Am in panels A–F.
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WNTs on ES cell self-renewal.
To further characterize the pluripotency of ES cells cultured
in the presence of WNT proteins, mouse chimeras were
generated using ES cells cultured in the presence of three
WNT proteins. ES cells were cultured in complete ES cell
medium without LIF using C-STO, C-STO-Wnt3, C-STO-
Wnt5a, and C-STO-Wnt6 feeders, respectively, for 5 days in
each passage. Most ES cells on C-STO lost their ability to form
colonies after 2 passages, so no attempts were made at chimera
formation. However, ES cells cultured on WNT-producing
feeders were continuously passed for 6 times before being used
for microinjection to generate chimeras. As shown in Table 3,
ES cells cultured on WNT-producing feeder cells were able to
contribute 25–100% in different chimeras. Importantly, most
of these ES cells after extended culture still contained a normalkaryotype (data not shown), a prerequisite for germ-line
transmission. Five male chimeras obtained from each of the
three ES cell cultures were further used to mate with wild-type
C57Bl6 females, and all were able to contribute to the germ-
line. This is shown in Fig. 2G by the presence of agouti
offspring.
WNT5A and WNT3 similarly inhibit b-catenin phosphorylation
in ES cells
LIF supports the self-renewal of mouse ES cells by
activating STAT3, and BMP4 exerts its effect by inhibiting
MAP kinase pathways and up-regulating Id genes (Qi et al.,
2004; Ying et al., 2003). Sato et al. reported that WNT3A
conditioned-medium maintained Oct4 expression in ES cells
(Sato et al., 2004). WNT proteins elicit three separate signaling
Table 2
Differential expression of putative growth factors in A-STO and C-STO
(extracted from microarray data)
Gene Id A-STO C-STO Folds Accession Gene name
101571_g_at 2330 (P) 12 (A) 188 X76066 Igfbp4
98623_g_at 4299 (P) 146 (A) 29 X71922 Igf2
95546_g_at 285 (P) 21 (A) 14 X04480 Igf1
99390_at 383 (P) 34 (A) 11 M89798 Wnt5a
103735_at 145 (P) 16 (A) 9 M89800 Wnt6
99067_at 814 (P) 104 (P) 7.8 X59846 Gas6
102044_at 667 (P) 121 (P) 5.5 AF100777 Wisp1
98817_at 634 (P) 122 (A) 5.2 Z29532 Follistatin
101969_at 554 (P) 147 (A) 3.8 D50263 Dan
102898_at 43 (P) 12 (A) 3.7 X72307 Hgf
92415_at 299 (P) 88 (A) 3.4 L15435 Tnf member 9
92730_at 239 (P) 67 (A) 3.4 L07264 Hbegf-like
94704_at 139 (P) 43 (A) 3.3 AF100778 Wisp2
104388_at 471 (P) 142 (M) 3.3 U49513 CC chemokine
92777_at 480 (P) 175 (P) 2.7 M32490 Igfbp10
102751_at 504 (P) 185 (P) 2.7 M32745 Tgfh 3
97997_at 725 (P) 270 (P) 2.7 U88566 sFrp1
102298_at 83 (P) 33 (A) 2.6 M17298 Ngfh
92738_at 202 (P) 86 (P) 2.4 D49921 Gdnf
101450_at 1012 (P) 418 (P) 2.4 M21952 Mg-csf
103520_at 125 (P) 57 (P) 2.2 M95200 Vegf
93294_at 292 (P) 141 (P) 2 M70642 Ctgf
93883_at 2035 (P) 1178 (P) 1.7 K03235 Proliferin
102727_at 458 (P) 270 (P) 1.7 X55573 Bdnf
94833_at 617 (P) 373 (P) 1.7 M91380 Follistatin-like
100457_at 324 (P) 202 (P) 1.6 X84037 E-selectin ligand-1
99577_at 535 (P) 367 (P) 1.5 M57647 Mgf
93455_s_at 105 (P) 116 (P) 0.9 X56848 Bmp4
A, absence; P, presence; M, marginal.
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the WNT/polarity pathways (Barker et al., 2000; He, 2003; He
et al., 2004; Huelsken and Behrens, 2002; Logan and Nusse,
2004; Miller, 2002; Moon et al., 2004; Nusse, 2003; Strutt,
2003; Veeman et al., 2003). Of these, the WNT/h-catenin
pathway is the best characterized. Furthermore, the WNT/h-
catenin and WNT/Ca2+pathways have been shown to antago-
nize each other (Ishitani et al., 2003; Torres et al., 1996). For
the WNT/h-catenin pathway, WNTs bind frizzled receptors and
co-receptors LRP5/6 to signal through Disheveled and Axin,
by an unclear mechanism, to dissociate an existing protein
complex containing adenomatous polyposis coli (APC), casein
kinase I (CKI), glycogen synthase kinase 3h (GSK3h), and h-
catenin. Since GSK3h within the complex phosphorylates h-
catenin to target the latter for degradation by the proteasomal
pathway, dissociation of GSK3h and h-catenin by WNT
signals results in the accumulation of h-catenin in the
cytoplasm. Consequently, h-catenin translocates to the nucleus
to bind members of the TCF (T cell factor)/LEF (lymphoid
enhancer family) transcription factors. In the absence of h-
catenin, TCF/LEF factors associate with histone deacetylase 1
(HDAC1) to serve as transcriptional repressors, while h-
catenin can replace HDAC1 to form a complex with TCF/
LEF to elicit sequence-specific transcriptional activation of the
target genes (Kioussi et al., 2002).
To further investigate the roles of WNT signaling in
pluripotency, we examined the expression of WNT receptorsin ES cells. Total RNAs from three ES cell lines were used for
RT-PCR. Indeed, all 9 frizzled genes are detected in ES cells
despite some variations in expression levels among the cell
lines (Fig. 3A), indicating that ES cells have the capacity to
respond to multiple WNT proteins. WNT5A has been shown to
signal through WNT/Ca2+ pathway to antagonize the WNT/h-
catenin pathway in most biological systems (Ishitani et al.,
2003; Liu et al., 1999; Torres et al., 1996). However, when co-
expressed with frizzled 5 receptor in Xenopus embryos,
WNT5A was able to signal through h-catenin pathway to
trigger secondary axis formation (He et al., 1997; Ishikawa et
al., 2001), indicating that the function of WNT5A is dependent
on the relative abundance of different frizzled receptors on the
target cells. As shown in Fig. 3A, frizzled 5 is indeed expressed
at high levels in ES cells, similar to those in the brain and
E15.5 mouse embryos. The expression of frizzled 5 in both
human and mouse ES cells was also revealed by gene
expression profiling (Ramalho-Santos et al., 2002; Sato et al.,
2003). Furthermore, WNT5A- and WNT3-conditioned media
were equally potent in inhibiting the phosphorylation of h-
catenin (Fig. 3B), indicating that WNT5A signals to stabilize
h-catenin in ES cells.
Direct activation of b-catenin prevents ES cell differentiation
WNT proteins are potent inhibitors of ES cell differentia-
tion, and the h-catenin pathway is strongly implicated in this
biological process based on our study and previous reports
(Kielman et al., 2002; Sato et al., 2004). However, almost all
the data published or presented above only indirectly indicated
a role for h-catenin. Thus, further evidence is needed to
directly reveal a role of h-catenin in preventing ES cell
differentiation. Since the existence of three WNT pathways
complicates further investigation, using WNT-conditioned
medium or purified WNT proteins is not ideal to dissect the
h-catenin pathway. In order to overcome these problems and to
obtain clean and direct evidence that h-catenin plays a role in
ES cell self-renewal, we decided to establish ES cell lines with
conditional activation of h-catenin alone, without disturbing h-
catenin-regulating components or the other WNT pathways.
For this, we sub-cloned a fusion protein of a constitutively
active h-catenin (S33Y) and a mutant ligand-binding domain
of estrogen receptor a into CAG-puro to generate CAG-h-
catenin-ER (Fig. 4A) (Van Mater et al., 2003) and used it to
establish several stable ES cell lines.
In the absence of 4-OHT, the fusion protein is trapped in the
cytoplasm, which renders the protein inactive. While in the
presence of 4-OHT, a conformational alteration in ER allows
h-catenin to translocate to the nucleus. As shown in Figs. 4B
and C, when CAG-h-catenin-ER ES cells were cultured on C-
STO cells in ES cell medium containing 10% FBS without LIF,
all of them formed spread colonies with little Oct4-GFP
expression after 7 days. However, when 100 nM 4-OHT was
added to the medium, ES cells formed compact colonies with
robust Oct4-GFP expression (Figs. 4D and E). Thus, direct
activation of h-catenin without altering other cellular compo-
nents recapitulates the effect of WNT proteins on ES cells. This
Fig. 2. Expression of WNT proteins in C-STO feeder cells prevents ES cell differentiation. ES cells were cultured similarly as in Fig. 1, except that medium
contained 10% FBS and no LIF. (A and B) Fluorescent and dark-field photomicrographs showing ES cells cultured for 7 days on C-STO feeder cells transfected with
the control vector, CAG-puro. All colonies spread with no Oct4-GFP expression. (C and D) ES cells cultured on C-STO cells transfected with CAG-Wnt5a under the
same culture conditions as for panels A and B. Compact colonies with minimum loss of GFP were shown. Panels E and F identical to panels C and D except that C-
STO cells were transfected with CAG-Wnt3. (G) A male mouse chimera (arrow), generated from ES cells that were cultured on C-STO-Wnt5a feeder, and a C57Bl/6
female successfully mated and transmitted the ES cell-derived genome to the offspring (agouti pups). Scale bar = 700 AM for panels A–F.
J. Hao et al. / Developmental Biology 290 (2006) 81–9186observation provides direct evidence to further validate reports
that the GSK3h specific inhibitor, BIO, or mutations in APC
prevent ES cell differentiation (Kielman et al., 2002; Sato et al.,
2004).
Regulation of key transcription factors in ES cells by
WNT/b-catenin pathway
To further dissect the WNT/h-catenin pathway in ES cells,
we examined, by semi-quantitative RT-PCR, the regulation of
transcription factors known to play roles in preventing ES cell
differentiation, including Oct4, Nanog, Id1-3, and Stat3. It was
assumed that without active WNT/h-catenin signaling, expres-
sion for some of these factors would be down-regulated, whileactivation of the pathway would maintain the expression. To
accomplish this, we first compared the expression of these
genes in ES cells cultured with and without WNT3A-
conditioned serum-free medium for 6 h. As shown in Fig.
4F, the up-regulation of known target genes of h-catenin,
including Axin2, Brachyury, and Pitx2, was confirmed (Briata
et al., 2003; Kioussi et al., 2002; Leung et al., 2002; Vonica and
Gumbiner, 2002; Yamaguchi et al., 1999), indicating that the
system worked as expected. We, therefore, further studied the
expression of the intended genes. Id2 and Stat3 were detected
at higher levels in ES cells treated with WNT3A, while Id3 and
Nanog were detected at a higher level in control ES cells.
WNT3A appeared to have little acute effect on the other genes.
The up-regulation of Id2 was consistent with a previous report
Table 3
Contribution of ES cells cultured on C-STO-Wnt3, C-STO-Wnt5a, and C-STO-
Wnt6 feeder cells to chimeric mice based on coat color
Feeder
cells
Number of
Chimeras
Percentage of ES cell contribution
based on coat colors
C-STO-Wnt3 6 males 70, 85, 70, 25, 25, 100
7 females 90, 75, 60, 40, 25, 100, 50
C-STO-Wnt5a 13 males 75, 80, 90, 25, 100, 50, 75,
75, 50, 40, 20, 40, 20, 30
13 females 40, 80, 85, 80, 75, 40, 75,
40, 50, 30, 90, 70, 70
C-STO-Wnt6 9 males 100, 100, 50, 40, 25, 100,
100, 90, 60
8 females 40, 40, 50, 40, 40, 90, 90, 80
Fig. 3. Expression of frizzled receptors and regulation of h-catenin by WNTs in
mouse ES cells. (A) Expression of frizzled receptors in mouse ES cells. RNAs
from 3 different ES cell lines were used for RT-PCR with E15.5 embryos and
adult brain as controls to evaluate the relative levels of expression. cDNAs were
normalized by Hprt. (B) Western blots to detect total h-catenin and phospho-h-
catenin in ES cells after treatment with conditioned media from C-STO
transfected with CAG-puro, C-STO-Wnt3, and C-STO-Wnt5a for 2 h and 5 h,
respectively. The levels of phospho-h-catenin were significantly lower in
WNT3 and WNT5A treated cells than the controls.
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human embryonal carcinoma (EC) cells (Willert et al., 2002).
However, regulation of Id3, Stat3, and Nanog by WNT
signaling has not been reported.
To test whether the differential regulation of Id2, Id3,
Nanog, and Stat3 by WNT3A is through the activation of h-
catenin or other pathways, ES cells expressing h-catenin-ER
were treated with 100 nM 4-OHT at 4 time points for RT-
PCR. As shown in Fig. 4G, the up-regulation of Stat3 was
indeed due to activated h-catenin. However, the treatment had
no appreciable effect on the expression of Id2. Interestingly,
the expression of Nanog appeared relatively constant in ES
cells treated with 4-OHT. In the absence of 4-OHT, Nanog
was up-regulated at 2 or 8 h, likely reflecting a compensatory
reaction by ES cells due to lack of active WNT/h-catenin
signaling. Obviously, such compensation is not sufficient to
prevent ES cell differentiation in the absence of WNT
signaling. Id3 appeared down-regulated by h-catenin (consis-
tent with WNT3A treatment). Therefore, only the increase of
Stat3 mRNA was consistent with a positive role of h-catenin
in maintaining pluripotency. A two-fold increase of Stat3
mRNA by activated h-catenin was further demonstrated by
subsequent real-time PCR and microarray analysis (data not
shown).
To examine whether the up-regulation of Stat3 transcripts
resulted in an increase in STAT3 proteins, Western blots were
carried out at two times, 4 and 8 h, after the addition of 100 nM
4-OHT to ES cells cultured in serum-free medium. As shown
in Fig. 4H, more STAT3 proteins were detected in ES cells
treated with 4-OHT at both times (about 2- to 3-fold higher
than in controls). To investigate whether the up-regulation of
Stat3 was a direct or indirect effect of h-catenin activation,
cyclohexamide (10 Ag/ml) was used to block protein synthesis.
As shown in Fig. 4I, addition of cyclohexamide did not block
the up-regulation of Stat3 by 4-OHT, indicating that new
protein synthesis was not required for h-catenin to increase the
level of Stat3 mRNA.
Low concentrations of LIF synergize with WNT proteins to
prevent ES cell differentiation
The fact that activation of the WNT/h-catenin pathway
results in an increase in STAT3 proteins (2- to 3-fold)suggests that this pathway may sensitize and cooperate with
the LIF/JAK-STAT pathway in ES cells. In mouse ES cells,
LIF or other IL6 members activate JAK kinase that in turn
phosphorylates and activates STAT3 (Niwa et al., 1998). C-
STO expressing WNT3, WNT5A, or WNT6 can support ES
cell propagation in medium containing 10% FBS without
exogenous LIF (Fig. 2). Adding LIF to such cultures did not
significantly improve the rate of proliferation of the
undifferentiated ES cells (data not shown). As the compo-
sition of FBS is poorly defined and serum contains different
levels of numerous growth factors, we decided to use
serum-free medium to test the idea that WNT/h-catenin
pathway cooperates with LIF to inhibit ES cell differenti-
ation. Since STO cells survived poorly in serum-free
medium, L cells and L-Wnt3a cells were used as feeders
since they do survive well under these conditions.
As shown in Figs. 5A–D, after ES cells were cultured on
L-Wnt3a cells with serum-free medium for 7 days, all ES
cell colonies spread, differentiated, and lost Oct4-GFP
expression just as ES cells cultured on L cells. Thus,
WNT/h-catenin alone was not sufficient to prevent ES cell
differentiation in the absence of serum. However, ES cells
cultured on L-Wnt3a feeders in the same medium containing
Fig. 4. Activation of h-catenin mimics WNT effect on ES cells. (A) Schematic representation of CAG-h-catenin-ER construct. (B and C) The fluorescent and dark-
field photomicrographs showing h-catenin-ER ES cells cultured on C-STO cells for 7 days. All ES cell colonies spread with little Oct4-GFP expression after culture
in medium containing10% FBS without LIF or 4-OHT. Panels D and E same as in panels B and C except that ES cells were cultured with 100 nM 4-OHT. Most of
the ES cell colonies were tightly formed with robust Oct4-GFP expression. (F) Differential expression of WNT/h-catenin target genes and key transcription factors
(Id1-3, Nanog, Oct4, and Stat3) in ES cells cultured in L cell-conditioned serum-free medium (containing 10% KSR) and L-Wnt3a-conditioned serum-free medium
for 6 h (without LIF). The levels of Axin2, Brachyury, Pitx2, Id2, and Stat3 were higher while Id3 and Nanog appeared lower in WNT3A treated cells than in
control cells. (G) Differential expression of key transcription factors in h-catenin-ER ES cells with or without 4-OHT at different time points in serum-free medium.
Id1 expression gradually increased during the culture but not affected by 4-OHT. Id2 expression remained constant at all time points and unaffected by 4-OHT. Id3
expression was constant at all time points in the absence of 4-OHT but down-regulated by 4-OHT. Nanog expression remained constant in the presence of 4-OHT
and increased in the absence of 4-OHT. Stat3 appeared up-regulated by 4-OHT. Oct4 expression appeared unaffected by 4-OHT at all time points. (H) Western blots
detecting STAT3 proteins in h-catenin-ER ES cells cultured with or without 100 nM 4-OHT in serum-free medium without LIF for 4 and 8 h. STAT3 proteins were
2- to 3-fold more abundant in cells treated with 4-OHT than without 4-OHT. a-Tubulin was used for normalization. (I) RT-PCR showing that the up-regulation of
Stat3 mRNA by 4-OHT was not blocked by cyclohexamide (CHX). Scale bar = 700 AM in panels B–E.
J. Hao et al. / Developmental Biology 290 (2006) 81–9188only 10 U/ml LIF formed compact colonies with little loss
of Oct4-GFP expression (Figs. 5E–F) although these
colonies appeared smaller than those cultured in mediumcontaining FBS due to reduced rate of proliferation.
Nevertheless, ES cells cultured on L cells with 10 U/ml
LIF failed to prevent ES cell differentiation (Figs. 5G–H).
Fig. 5. WNT and LIF have synergistic effect in preventing ES cell differentiation. (A and B) Fluorescent and dark-field photomicrographs showing a spread ES cell
colony after culturing on L cells for 8 days with serum-free medium in the absence of LIF. All cells lost Oct4-GFP. Panels C and D same as in panels A and B except
that ES cells were cultured on L-Wnt3a cells. Almost all cells lost Oct4-GFP expression. (E and F) Same as panels C and D except that 10 U/ml LIF was added to the
culture. Compact colonies were formed with robust Oct4-GFP expression. Panels G and H same as in panels A and B except that 10 U/ml LIF was added to the culture.
The colony spread and most cells lost Oct4-GFP, indicating that 10 U/ml LIF was not sufficient to prevent ES cell differentiation. Scale bar = 700 AM in panels A–H.
J. Hao et al. / Developmental Biology 290 (2006) 81–91 89Thus, WNTs and LIF have synergistic effect that can be
explained by the fact that they both regulate the activity of
STAT3. The former increases Stat3 mRNA, while the latter
promotes the phosphorylation of STAT3 proteins (see
Supplemental Fig. 1).Fig. 6. A model of maintaining pluripotency of mouse ES cells by BMP4, LIF, and
phosphorylated by the type I receptors, then form complexes with SMAD4 to act a
triggered signal also inhibits ERK and p38 MAP kinases in mouse ES cells (Qi et al.
to prevent their nuclear import (Pera et al., 2003). Thus, suppression of MAPKs by B
binding to its receptor complex, GP130 activates JAK kinase that in turn phos
pluripotency (Smith, 2001). In addition, LIF has been shown to activate ERK-MAPK
signaling and may account for the synergistic effect of BMP4 and LIF in supporting
and downstream disheveled to result in the accumulation of h-catenin in the cytopla
transcription followed by STAT3 protein accumulation in the cytoplasm. STAT3
synergistic effect of WNT and LIF.Discussion
Our current study shows that mouse ES cells express high
levels of frizzled 5 receptor and are able to respond to WNT5A
through the h-catenin pathway. Evidence also stronglyWNTs. Upon BMP4/receptor complex formation, SMAD1 and/or SMAD5 are
s transcription factors and up-regulate the Id genes (Ying et al., 2003). BMP4-
, 2004). MAPKs have been shown to phosphorylate SMADs in the linker region
MP4 may further facilitate SMAD1/5 nuclear localization in ES cells. Upon LIF
phorylates STAT3. Phospho-STAT3 acts as transcription factor to maintain
pathway to cause ES cell differentiation. Such effect can be inhibited by BMP4
ES cell self-renewal. WNT proteins signal through frizzled receptors, LRP5/6,
sm and nucleus. h-Catenin forms a complex with TCF/LEF to stimulate Stat3
proteins are activated by LIF-triggered JAK kinase. This can account for the
J. Hao et al. / Developmental Biology 290 (2006) 81–9190indicates that the WNT/h-catenin pathway plays a critical role
in the propagation of hematopoietic stem cells (HSCs). Among
the WNT proteins shown to have this effect are WNT1,
WNT2B, WNT3A, WNT5A, and WNT10 (Austin et al., 1997;
Murdoch et al., 2003; Reya et al., 2003; Van Den Berg et al.,
1998; Willert et al., 2003). Thus, WNT5A is implicated in h-
catenin pathway in HSCs also. We observed that C-STO-
Wnt5a was as potent as C-STO-Wnt3 in maintaining the
pluripotency of mouse ES cells and in inhibiting h-catenin
phosphorylation. Moreover, the effect of WNT5A on ES cells
was not unique to one particular ES cell line. In fact, we
examined its effect on 5 different lines, and the results were
always the same. It is properly noted that our results contradict
an earlier report which suggested that, unlike WNT1 and
WNT3A, WNT5A did not signal through h-catenin in ES cells
to up-regulate Brachyury (Arnold et al., 2000). There are
significant differences between these two reports in terms of
experimental procedures. For example, Arnold et al. used
NIH3T3 cells as feeders to express WNT proteins and the ES
cells were cultured in buffalo rat liver (BRL) conditioned
medium. Under these conditions, ES cells might express
frizzled receptors differently and, consequently, show different
response to WNT proteins.
It is worth noting that compared with other WNT/h-catenin
target genes, such as Axin2, Brachyury, and Pitx2, the up-
regulation of Stat3 by h-catenin pathway appears modest (2- to
3-fold). This is likely because ES cells already have a relatively
high level of basal Stat3 expression that is essential for
maintaining ES cell pluripotency, while other target genes may
not be essential for ES cell self-renewal. It has been
documented that modest change in Oct4 expression can
dramatically switch ES cell fates. For example, a level below
50% of normal Oct4 expression causes ES cells to adopt a
trophoblast identity, while a level above 150% causes ES cells
to become primitive endoderm (Niwa et al., 2000). Thus, a
level between 50 and 150% of the normal Oct4 expression in
ES cells is essential to maintain pluripotency. By the same
token, one may not expect an absence or a very low level of
Stat3 expression in ES cells to begin with (before WNT or 4-
OHT treatment) because absence of STAT3 activity would
have caused those cells to differentiate and lose ES cell
property.
As summarized in Fig. 6, different signaling pathways
triggered by LIF, BMPs, and WNTs inhibit mouse ES cell
differentiation and cross-communicate through MAP kinases
and STAT3 proteins. Although the WNT/h-catenin pathway
has been implicated previously in preventing ES cell differen-
tiation, it has not been shown how this pathway functions in ES
cells. Here, we provide evidence that activation of h-catenin
alone is necessary and sufficient to recapitulate the effect of
WNTs on ES cells in a serum-dependent manner. Our limited
screen identified Stat3 as a target gene of this pathway,
identifying one component of the molecular mechanisms of
WNT/h-catenin signaling in ES cells. Our study also shows
that the up-regulation of STAT3 proteins by WNT/h-catenin is
incapable of inhibiting ES cell differentiation unless serum or
LIF is added to the culture. Thus, WNT/h-catenin and LIFmust converge on STAT3 to accomplish their biological
functions. Addition of cyclohexamide at 10 Ag/ml to ES cell
culture did not block the up-regulation of Stat3 transcription by
h-catenin, suggesting that Stat3 may be a direct target of h-
catenin-LEF/TCF complex. There are several LEF/TCF mem-
bers expressed in ES cells, including TCF1-4 and LEF1. The
first intron of mouse Stat3, about 30 kb in size, contains more
than 30 consensus LEF/TCF binding sites (data not shown).
However, there is no consensus LEF/TCF binding site in the
defined promoter region of mouse Stat3 (Ichiba et al., 1998),
making it a challenging task to further dissect the relationship
of WNT/h-catenin pathway with Stat3 regulation at the
molecular level.
It is important to note that in addition to IL6 family members,
serum contains other factors playing positive roles in preventing
ES cell differentiation, such as ACTH (Ogawa et al., 2004).
Thus, IL6 members may only represent part of multiple serum
factors that co-operatively inhibit ES cell differentiation with
WNT proteins. It is also worth noting that although the
combination of WNT/h-catenin pathway and serum factors is
able to maintain long-term ES cell culture with C-STO as feeder
cells, this combination is not sufficient to prevent ES cell
differentiation in feeder-free culture (data not shown). There-
fore, other factors produced by feeder cells are still required, and
their identity should be under further investigation.
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